Stay updated with breaking news from Clinical Research Programs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dr. Michael Pishvaian, Principal Investigator of Phase III TIGeR-PaC Clinical Trial, will Discuss Recent Interim Analysis and its Potential Practice-Changing Impact in Oncology ... | June 12, 2023
Company to Present Interim Analysis Secondary Endpoint Data Including Progression-free Survival from Phase III TIGeR-PaC Study, a Multi-center Open-label Study Evaluating RenovoGem™ to Treat... | May 25, 2023
Investegate announcements from MorphoSys AG, Ad hoc: MorphoSys Stops Work and Operations on Pre-Clinical Research Programs and Reduces Workforce at its Germany Headquarters
Take a closer look at the historical context and details of Biden's ambitious new campaign to defeat cancer.